FDA advisors endorse weight–loss drug Qnexa
In a reversal, an FDA advisory committee backs the weight–loss drug Qnexa despite health risks after its maker, Vivus, promises strict oversight. By Shari Roan, Los Angeles Times A panel of medical experts voted overwhelmingly Wednesday to endorse the …
See all stories on this topic »